ArticleFrontiers in endocrinology2025
Neutrophil percentage-to-albumin ratio as a novel hematologic biomarker for predicting arteriogenic erectile dysfunction.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The neutrophil percentage-to-albumin ratio (NPAR) is a novel composite marker reflecting both inflammatory and nutritional status. However, its association with arteriogenic erectile dysfunction (AED) has not been previously investigated. This study aimed to evaluate the relationship between NPAR and AED and to determine its diagnostic performance compared with conventional hematologic parameters. Methods: A total of 265 men were enrolled from three hospitals between April 2023 and August 2025, including 115 with AED, 53 with venogenic ED (VED), and 97 healthy controls. Erectile function was assessed by the five-item International Index of Erectile Function (IIEF-5), nocturnal penile tumescence and rigidity (NPTR) test and color duplex Doppler ultrasonography (CDDU) was used to classify ED subtypes. Laboratory parameters, including white blood cell (WBC) count, neutrophil percentage (NP), albumin, and NPAR, were measured. Group differences were analyzed using ANOVA or the Kruskal-Wallis test, and independent predictors of AED were identified using multivariate logistic regression. Diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis. Subgroup analyses were conducted to assess robustness. Results: Compared with controls, individuals with AED exhibited significantly higher WBC levels (5.97 ± 1.13 vs. 5.45 ± 0.90 × 10 Conclusions: Elevated NPAR levels were significantly associated with AED. Compared with WBC and its individual components, NPAR exhibited superior discriminative ability for identifying AED. These findings suggest that NPAR may serve as a convenient and cost-effective hematologic parameter for assessing vascular risk in men with ED, although prospective studies are needed to validate this association.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.